Home/Filings/4/0001104659-17-061846
4//SEC Filing

Le NgocDiep T. MD, PhD 4

Accession 0001104659-17-061846

CIK 0001526119other

Filed

Oct 10, 8:00 PM ET

Accepted

Oct 11, 8:34 PM ET

Size

5.3 KB

Accession

0001104659-17-061846

Insider Transaction Report

Form 4
Period: 2017-10-09
Le NgocDiep T. MD, PhD
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-10-09+300,000300,000 total
    Exercise: $4.63Exp: 2027-10-09Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]25% of this option will vest on October 9, 2018 and 6.25% of this option will vest at the end of each successive three-month period thereafter until October 9, 2021.

Documents

1 file

Issuer

Verastem, Inc.

CIK 0001526119

Entity typeother

Related Parties

1
  • filerCIK 0001719331

Filing Metadata

Form type
4
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 8:34 PM ET
Size
5.3 KB